Additionally, by employing chemogenetic CRISPR-Cas9 screens, we discovered that SMO inhibition acts synergistically with DNMT1 inhibition in suppressing tumor proliferation in murine as well as PDOX (patient-derived xenografts organoids) SHH-MB models. The gene discussed is DNMT1; the disease is neoplasm.